Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone with Salvage Chemotherapy in R/R AML
NCT03765541Phase 3Terminated
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Jan 2020
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in acute myeloid leukemia (AML), sponsored by Centre hospitalier universitaire de Toulouse. Started Jan 2020; status: terminated.
02
Drugs
dexamethasone
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT03765541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03765541.